A study of a revolutionary new approach to the treatment of obesity discusses the FDA's approval of a new appetite-control drug, Redux (dexfenfluramine), that produces dramatic results with fewer side effects and the use of Redux in a weight-loss program. 75,000 first printing. $75,000 ad/promo.
About Sheldon Levine
See more books from this Author
Published September 3, 1996
by William Morrow.
Health, Fitness & Dieting, Professional & Technical.